{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:55:55Z","timestamp":1789966555017,"version":"4.0.1"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Neurosurgery, Sir Charles Gairdner Hospital"},{"name":"Neurotrauma Research Program of Western Australia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.pharmthera.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T07:39:31Z","timestamp":1433576371000},"page":"36-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties"],"prefix":"10.1016","volume":"153","author":[{"given":"Bruno P.","family":"Meloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Anderton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"O'Hare Doig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Norman","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville W.","family":"Knuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5594","key":"10.1016\/j.pharmthera.2015.06.002_bb0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor\u2013PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1460-9568.2005.04340.x","article-title":"Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain","volume":"22","author":"Abe","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0015","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.bbamem.2012.06.006","article-title":"Cell surface binding and uptake of arginine- and lysine-rich penetrating peptides in absence and presence of proteoglycans","volume":"1818","author":"Amand","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4522(02)00709-1","article-title":"Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal\u2013glial cell cultures","volume":"116","author":"Aono","year":"2003","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chembiol.2012.05.022","article-title":"Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm","volume":"19","author":"Appelbaum","year":"2012","journal-title":"Chemistry and Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-4159.2007.04618.x","article-title":"Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-jun N-terminal kinase","volume":"102","author":"Arthur","year":"2007","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharmthera.2015.06.002_bb0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.mcn.2011.02.003","article-title":"Excitotoxic neuroprotection and vulnerability with CaMKII inhibition","volume":"46","author":"Ashpole","year":"2011","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2015.06.002_bb0040","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.1113761109","article-title":"A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage","volume":"109","author":"Bach","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H","article-title":"Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia","volume":"21","author":"Barone","year":"2001","journal-title":"Med Res Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0050","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1096\/fj.12-216176","article-title":"Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis","volume":"27","author":"Bechara","year":"2013","journal-title":"FASEB Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/meth.2001.1186","article-title":"TAT-mediated protein transduction into mammalian cells","volume":"24","author":"Becker-Hapak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jnc.12176","article-title":"Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption","volume":"126","author":"Bell","year":"2013","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbi.2009.11.001","article-title":"JNK inhibition and inflammation after cerebral ischemia","volume":"24","author":"Benakis","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0070","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-4159.2010.06705.x","article-title":"Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition","volume":"113","author":"Bessero","year":"2010","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molmed.2004.03.008","article-title":"Use of cell-permeable peptides to prevent neuronal degeneration","volume":"10","author":"Borsello","year":"2004","journal-title":"Trends Mol Med"},{"issue":"9","key":"10.1016\/j.pharmthera.2015.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0085","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1161\/STROKEAHA.111.618801","article-title":"Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor","volume":"42","author":"Br\u00e5tane","year":"2011","journal-title":"Stroke"},{"issue":"31","key":"10.1016\/j.pharmthera.2015.06.002_bb0090","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1523\/JNEUROSCI.4474-03.2004","article-title":"Protein kinase C delta mediates cerebral reperfusion injury in vivo","volume":"24","author":"Bright","year":"2004","journal-title":"J Neurosci"},{"issue":"1144","key":"10.1016\/j.pharmthera.2015.06.002_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2007.01.113","article-title":"DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo","volume":"4","author":"Bright","year":"2007","journal-title":"Brain Res"},{"issue":"43","key":"10.1016\/j.pharmthera.2015.06.002_bb0100","doi-asserted-by":"crossref","first-page":"37778","DOI":"10.1074\/jbc.M111.255455","article-title":"Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)","volume":"286","author":"Brittain","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.2345","article-title":"Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex","volume":"17","author":"Brittain","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4161\/chan.18919","article-title":"Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model","volume":"6","author":"Brittain","year":"2012","journal-title":"Channels"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/bmc.2010.016","article-title":"Cell penetrating peptides can exert biological activity: a review","volume":"1","author":"Brugnano","year":"2010","journal-title":"Biomolecular Concepts"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0120","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.M113.518472","article-title":"Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-d-aspartate (NMDA) receptor and Na+\/Ca2+ exchanger and regulates their functional activity","volume":"289","author":"Brustovetsky","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1471-4159.2011.07209.x","article-title":"Proteomic analysis of cPKC\u03b2II-interacting proteins involved in HPC-induced neuroprotection against cerebral ischemia of mice","volume":"117","author":"Bu","year":"2011","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.cdd.4401988","article-title":"Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons","volume":"14","author":"Centeno","year":"2007","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1074\/jbc.M112.421354","article-title":"Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo","volume":"288","author":"Chambers","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/MN:28:1:51","article-title":"Collapsin response mediator proteins (CRMPs): Involvement in nervous system development and adult neurodegenerative disorders","volume":"28","author":"Charrier","year":"2003","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/jcbfm.2015.16","article-title":"Tat-NR2B9c prevents excitotoxic neuronal superoxide production","volume":"35","author":"Chen","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"10.1016\/j.pharmthera.2015.06.002_bb0150","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/sj.cdd.4402202","article-title":"The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability","volume":"14","author":"Colombo","year":"2007","journal-title":"Cell Death Differ"},{"issue":"7388","key":"10.1016\/j.pharmthera.2015.06.002_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature10841","article-title":"Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain","volume":"483","author":"Cook","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2010.12.077","article-title":"The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains","volume":"1378","author":"Corrigan","year":"2011","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jnc.12391","article-title":"The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96\u2013110","volume":"128","author":"Corrigan","year":"2014","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10989-010-9234-8","article-title":"Attenuation of neuronal death by peptide inhibitors of AP-1 activation in acute and delayed in vitro ischaemia (oxygen\/glucose deprivation) models","volume":"17","author":"Craig","year":"2011","journal-title":"Int J Pept Res Ther"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/NEN.0b013e3181ac6b70","article-title":"Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95","volume":"68","author":"Dykstra","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2009.05.018","article-title":"Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape","volume":"138","author":"El-Sayed","year":"2009","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2007.12.036","article-title":"d-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats","volume":"152","author":"Esneault","year":"2008","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0190","doi-asserted-by":"crossref","first-page":"471-80","DOI":"10.1038\/nn.3637","article-title":"Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation","volume":"17","author":"Fan","year":"2014","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2014.02.011","article-title":"Glycosaminoglycans in the cellular uptake of drug delivery vectors \u2014 Bystanders or active players?","volume":"180","author":"Favretto","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2013.06.057","article-title":"Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides","volume":"557","author":"Feldman","year":"2013","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nbt0398-286","article-title":"Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death","volume":"16","author":"Ferrer-Montiel","year":"1988","journal-title":"Nat Biotechnol"},{"issue":"Pt 15","key":"10.1016\/j.pharmthera.2015.06.002_bb0210","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1242\/jcs.02460","article-title":"Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization","volume":"118","author":"Fotin-Mleczek","year":"2005","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0215","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0220","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.jcbfm.9600062","article-title":"Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway","volume":"25","author":"Gao","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/NCC:4:1:025","article-title":"A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage","volume":"4","author":"Gao","year":"2006","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0230","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garc\u00eda-Caballero","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0235","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/j.1460-9568.2008.06285.x","article-title":"Concepts of neural nitric oxide-mediated transmission","volume":"27","author":"Garthwaite","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0240","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1471-4159.2008.05797.x","article-title":"Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia\u2013ischemia","volume":"108","author":"Ginet","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2008.12.051","article-title":"Selective blockade of CaMKII-alpha inhibits NMDA-induced caspase-3-dependent cell death but does not arrest PARP-1 activation or loss of plasma membrane selectivity in rat retinal neurons","volume":"1256","author":"Goebel","year":"2009","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0250","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/jcbfm.2011.140","article-title":"Lack of neuroprotection of inhibitory peptides targeting Jun\/JNK following transient focal cerebral ischemia in spontaneously hypertensive rats","volume":"31","author":"Gow","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0255","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuroscience.2005.11.067","article-title":"Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways","volume":"139","author":"Guan","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm1016","article-title":"Temporal and spatial coordination of exocytosis and endocytosis","volume":"4","author":"Gundelfinger","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.pharmthera.2015.06.002_bb0270","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0275","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","article-title":"Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): A phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Hill","year":"2012","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0280","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/01.STR.0000131480.03994.b1","article-title":"d-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia","volume":"35","author":"Hirt","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/neu.2008.0565","article-title":"COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain","volume":"26","author":"Hoane","year":"2009","journal-title":"J Neurotrauma"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0290","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1089\/neu.2006.0254","article-title":"The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury","volume":"24","author":"Hoane","year":"2007","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0295","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bcp.2004.01.003","article-title":"Receptor endocytosis via ubiquitin-dependent and -independent pathways","volume":"67","author":"H\u00f6ller","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0300","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1006\/bbrc.1995.2040","article-title":"A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II","volume":"212","author":"Ishida","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.pharmthera.2015.06.002_bb0305","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1089\/neu.2012.2362","article-title":"Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice","volume":"29","author":"Jiang","year":"2012","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0310","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jnc.12070","article-title":"Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide","volume":"124","author":"Ju","year":"2013","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0315","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuint.2008.01.007","article-title":"Opioids modulate post-ischemic progression in a rat model of stroke","volume":"52","author":"Kao","year":"2008","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0320","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbr.2010.06.017","article-title":"COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat","volume":"214","author":"Kaufman","year":"2010","journal-title":"Behav Brain Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0325","doi-asserted-by":"crossref","first-page":"e51813","DOI":"10.1371\/journal.pone.0051813","article-title":"Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0330","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1471-4159.2005.03212.x","article-title":"Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity","volume":"94","author":"Lai","year":"2005","journal-title":"J Neurochem"},{"issue":"7539","key":"10.1016\/j.pharmthera.2015.06.002_bb0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature13974","article-title":"Modulation of the proteoglycan receptor PTP\u03c3 promotes recovery after spinal cord injury","volume":"518","author":"Lang","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0340","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12028-011-9641-5","article-title":"The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage","volume":"16","author":"Laskowitz","year":"2012","journal-title":"Neurocrit Care"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0345","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/neu.2006.0192","article-title":"COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury","volume":"24","author":"Laskowitz","year":"2007","journal-title":"J Neurotrauma"},{"issue":"19","key":"10.1016\/j.pharmthera.2015.06.002_bb0350","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1523\/JNEUROSCI.4578-12.2013","article-title":"The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death","volume":"33","author":"Li","year":"2013","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0355","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.106.103671","article-title":"Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis","volume":"318","author":"Li","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0360","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1523\/JNEUROSCI.14-06-03713.1994","article-title":"Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system","volume":"14","author":"Litwack","year":"1994","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0365","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/nm.1883","article-title":"Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex","volume":"14","author":"Liu","year":"2008","journal-title":"Nat Med"},{"issue":"25","key":"10.1016\/j.pharmthera.2015.06.002_bb0370","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1074\/jbc.M513490200","article-title":"Neuroprotection of Tat-GluR6-9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2015.06.002_bb0375","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2011.10.012","article-title":"CaMKII antisense oligodeoxynucleotides protect against ischemia-induced neuronal death in the rat hippocampus","volume":"314","author":"Liu","year":"2012","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2990.2009.01047.x","article-title":"The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats","volume":"36","author":"Liu","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0385","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2014.05.021","article-title":"Neurovascular coupling in hippocampus is mediated via diffusion by neuronal-derived nitric oxide","volume":"73","author":"Louren\u00e7o","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1525-0016(03)00135-7","article-title":"Cell surface adherence and endocytosis of protein transduction domains","volume":"8","author":"Lundberg","year":"2003","journal-title":"Mol Ther"},{"issue":"49","key":"10.1016\/j.pharmthera.2015.06.002_bb0395","doi-asserted-by":"crossref","first-page":"48529","DOI":"10.1074\/jbc.M306923200","article-title":"APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response","volume":"278","author":"Lynch","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.expneurol.2004.11.014","article-title":"A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury","volume":"192","author":"Lynch","year":"2005","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0405","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2013.11.011","article-title":"Endocytic trafficking of chemokine receptors","volume":"27","author":"Marchese","year":"2014","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4161\/chan.3.1.7864","article-title":"Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression","volume":"3","author":"Martel","year":"2009","journal-title":"Channels (Austin)"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0415","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm1315","article-title":"Endocytic recycling","volume":"5","author":"Maxfield","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neulet.2005.02.036","article-title":"Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic\u2013ischemic injury","volume":"381","author":"McAdoo","year":"2005","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0425","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-4159.2009.06459.x","article-title":"AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures","volume":"112","author":"Meade","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.6030\/1939-067X-2.1.21","article-title":"The application of cell penetrating peptides for the delivery of neuroprotective peptides\/proteins in experimental cerebral ischemia studies","volume":"2","author":"Meade","year":"2009","journal-title":"Journal of Experimental Stroke Translational Medicine"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0435","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2010.09.007","article-title":"AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid","volume":"1360","author":"Meade","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/jcbfm.2015.11","article-title":"Poly-arginine and arginine-rich peptides are neuroprotective in stroke models","author":"Meloni","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10571-013-9999-3","article-title":"The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures","volume":"34","author":"Meloni","year":"2014","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0450","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1159\/000306643","article-title":"c-Jun N-terminal kinase pathway inhibition in intracerebral hemorrhage","volume":"29","author":"Michel-Monigadon","year":"2010","journal-title":"Cerebrovasc Dis"},{"issue":"15-16","key":"10.1016\/j.pharmthera.2015.06.002_bb0455","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: Classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0460","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J Pept Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0465","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-4159.2007.05204.x","article-title":"Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease","volume":"105","author":"Nagel","year":"2008","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0470","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/bi0612824","article-title":"Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis","volume":"46","author":"Nakase","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0475","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.M008085200","article-title":"Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-d-aspartate receptor","volume":"276","author":"Nakazawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2015.06.002_bb0480","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nbd.2013.01.017","article-title":"Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage","volume":"54","author":"Nijboer","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0485","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbi.2009.09.008","article-title":"Inhibition of the JNK\/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic\u2013ischemic brain injury","volume":"24","author":"Nijboer","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.pharmthera.2015.06.002_bb0490","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ncb1039","article-title":"CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth","volume":"5","author":"Nishimura","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"9","key":"10.1016\/j.pharmthera.2015.06.002_bb0495","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/NEN.0b013e3181b20670","article-title":"c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion","volume":"68","author":"Ortolano","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0500","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nm.2263","article-title":"Uncoupling the dopamine D1\u2013D2 receptor complex exerts antidepressant-like effects","volume":"16","author":"Pei","year":"2010","journal-title":"Nat Med"},{"issue":"19","key":"10.1016\/j.pharmthera.2015.06.002_bb0505","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1523\/JNEUROSCI.5119-13.2014","article-title":"DAPK1\u2013p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death","volume":"34","author":"Pei","year":"2014","journal-title":"J Neurosci"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2015.06.002_bb0510","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awh700","article-title":"Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence","volume":"129","author":"Pei","year":"2006","journal-title":"Brain"},{"issue":"54","key":"10.1016\/j.pharmthera.2015.06.002_bb0515","first-page":"2","article-title":"CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy","volume":"8","author":"Piekarz","year":"2012","journal-title":"Mol Pain"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0520","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(00)01982-7","article-title":"Arginine-rich peptides are blockers of VR-1 channels with analgesic activity","volume":"481","author":"Planells-Cases","year":"2000","journal-title":"FEBS Lett"},{"issue":"24","key":"10.1016\/j.pharmthera.2015.06.002_bb0525","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1021\/bi5004102","article-title":"Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery","volume":"53","author":"Qian","year":"2014","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2015.06.002_bb0530","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/tra.12100","article-title":"Sialic acid linkage in glycosphingolipids is a molecular correlate for trafficking and delivery of extracellular cargo","volume":"14","author":"Ravindran","year":"2013","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0535","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroscience.2007.08.021","article-title":"Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of d-JNKI1 on c-Jun and caspase-3 activation","volume":"150","author":"Repici","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0540","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.nbd.2012.03.014","article-title":"Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury","volume":"46","author":"Repici","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/s13380-012-0002-4","article-title":"A peptide uncoupling CRMP-2 from the presynaptic Ca(2+) channel complex demonstrates efficacy in animal models of migraine and aids therapy-induced neuropathy","volume":"3","author":"Ripsch","year":"2012","journal-title":"Translational Neuroscience"},{"issue":"27","key":"10.1016\/j.pharmthera.2015.06.002_bb0550","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1021\/bi300454k","article-title":"Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides","volume":"51","author":"Rydberg","year":"2012","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008191","article-title":"Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease","volume":"4","author":"Sarantseva","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0560","doi-asserted-by":"crossref","first-page":"22","DOI":"10.6030\/1939-067X-5.1.22","article-title":"Peptides targeting the mitogen-activated protein kinase pathway (JNK\/Jun) fail to reduce infarct volume after permanent MCAO in Sprague-Dawley rats","volume":"5","author":"Si","year":"2012","journal-title":"J Exp Stroke Transl Med"},{"issue":"8","key":"10.1016\/j.pharmthera.2015.06.002_bb0565","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1101\/lm.1765710","article-title":"Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala","volume":"17","author":"Sinai","year":"2010","journal-title":"Learning and Memory"},{"issue":"4","key":"10.1016\/j.pharmthera.2015.06.002_bb0570","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0021-9258(19)39904-1","article-title":"Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function","volume":"265","author":"Smith","year":"1990","journal-title":"J Biol Chem"},{"issue":"42","key":"10.1016\/j.pharmthera.2015.06.002_bb0575","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1523\/JNEUROSCI.1207-08.2008","article-title":"Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand","volume":"28","author":"Soriano","year":"2008","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.pharmthera.2015.06.002_bb0580","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1460-9568.2010.07158.x","article-title":"c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus","volume":"31","author":"Spigolon","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0585","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/jcbfm.2013.153","article-title":"Uncoupling PSD-95 interactions leads to rapid recovery of cortical function after focal stroke","volume":"33","author":"Srejic","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0590","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jnr.23186","article-title":"Selective activation of protein kinase C\u220a in mitochondria is neuroprotective in vitro and reduces focal ischemic brain injury in mice","volume":"91","author":"Sun","year":"2013","journal-title":"J Neurosci Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2015.06.002_bb0595","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/STROKEAHA.107.506048","article-title":"Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat","volume":"39","author":"Sun","year":"2008","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0600","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nm.2064","article-title":"Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries","volume":"15","author":"Taghibiglou","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0610","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jnr.21874","article-title":"COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia","volume":"87","author":"Tukhovskaya","year":"2009","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0615","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2010.01.016","article-title":"NF-kappaB inhibition after neonatal cerebral hypoxia\u2013ischemia improves long-term motor and cognitive outcome in rats","volume":"38","author":"van der Kooij","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.pharmthera.2015.06.002_bb0620","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.2011.07535.x","article-title":"Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor","volume":"119","author":"Vaslin","year":"2011","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0625","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.21584","article-title":"Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia","volume":"65","author":"Vaslin","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0630","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12640-009-9012-6","article-title":"Unconjugated TAT carrier peptide protects against excitotoxicity","volume":"15","author":"Vaslin","year":"2009","journal-title":"Neurotox Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2015.06.002_bb0635","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1091\/mbc.E07-02-0185","article-title":"Dual mechanism of a natural CaMKII inhibitor","volume":"18","author":"Vest","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"27","key":"10.1016\/j.pharmthera.2015.06.002_bb0640","doi-asserted-by":"crossref","first-page":"20675","DOI":"10.1074\/jbc.M109.088617","article-title":"Effective post-insult neuroprotection by a novel Ca(2+)\/calmodulin-dependent protein kinase II (CaMKII) inhibitor","volume":"285","author":"Vest","year":"2010","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.pharmthera.2015.06.002_bb0645","first-page":"2717","article-title":"The stoichiometry of peptide-heparan sulfate binding as a determinant of uptake efficiency of cell-penetrating peptides","volume":"71","author":"Wallbrecher","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0650","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.0.CO;2-G","article-title":"Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide","volume":"173","author":"Wang","year":"1997","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.pharmthera.2015.06.002_bb0655","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1161\/STROKEAHA.114.006348","article-title":"Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.pharmthera.2015.06.002_bb0660","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000151639","article-title":"The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator","volume":"26","author":"Wiegler","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0665","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2006.12.020","article-title":"Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity","volume":"53","author":"Xu","year":"2007","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pharmthera.2015.06.002_bb0670","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1073858407309762","article-title":"Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences","volume":"14","author":"Xu","year":"2008","journal-title":"Neuroscientist"},{"issue":"26","key":"10.1016\/j.pharmthera.2015.06.002_bb0675","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1039\/c4ob00673a","article-title":"Interaction of amphiphilic \u03b1-helical cell-penetrating peptides with heparan sulphate","volume":"12","author":"Yang","year":"2014","journal-title":"Org Biomol Chem"},{"issue":"4","key":"10.1016\/j.pharmthera.2015.06.002_bb0680","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bpj.2009.05.052","article-title":"Real-time monitoring of transferrin-induced endocytic vesicle formation by mid-infrared surface plasmon resonance","volume":"97","author":"Yashunsky","year":"2009","journal-title":"Biophys J"},{"issue":"2","key":"10.1016\/j.pharmthera.2015.06.002_bb0685","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1523\/JNEUROSCI.1900-07.2008","article-title":"Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors","volume":"28","author":"Zhang","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2015.06.002_bb0690","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/neu.2006.0078","article-title":"Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury","volume":"24","author":"Zhang","year":"2007","journal-title":"J Neurotrauma"},{"issue":"18","key":"10.1016\/j.pharmthera.2015.06.002_bb0695","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1523\/JNEUROSCI.5661-12.2013","article-title":"Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries","volume":"33","author":"Zhang","year":"2013","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2015.06.002_bb0700","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2009.04.006","article-title":"Neuroprotection against neonatal hypoxia\/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation","volume":"218","author":"Zhou","year":"2009","journal-title":"Exp Neurol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725815001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725815001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T07:22:40Z","timestamp":1717917760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725815001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":140,"alternative-id":["S0163725815001175"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2015.06.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}